|[January 17, 2014]
Glancy Binkow & Goldberg LLP Announces Investigation of Nu Skin Enterprises, Inc.
LOS ANGELES --(Business Wire)--
Binkow & Goldberg LLP announces that it is investigating
potential claims on behalf of investors of Nu
Skin Enterprises, Inc. ("Nu Skin" or the "Company") (NYSE:NUS)
concerning possible violations of federal securities laws. The
investigation is focused on certain statements issued by Nu Skin
concerning the Company's operations.
Please contact us at (212) 682-5340, Toll-Free at (888) 773-9224, or at firstname.lastname@example.org
to discuss this matter. If you inquire by email please include your
mailing address, telephone number and number of shares purchased.
The investigation is related to news reports alleging that the Company
distribtes false information and conducts illegal business in China. On
January 15, 2014, China's Communist Party newspaper, The People's
Daily, alleged that Nu Skin had been misrepresenting its influence
and creditworthiness in Company brochures, and passing advertisements as
news reports. The newspaper subsequently alleged that the Company was
suspected of conducting illegal multi-level marketing activities in
China. Following this news, on January 15, 2014, the price of Nu Skin
shares dropped $21.24 per share, on heavy trading volume, to a closing
price of $115.23 per share. On January 16, 2014, China's state news
agency, Xinhua, said China's State Administration for Industry and
Commerce had ordered local authorities to investigate the recent media
reports about Nu Skin.
If you purchased Nu Skin shares, if you have information or would like
to learn more about these claims, or if you have any questions
concerning this announcement or your rights or interests with respect to
these matters, please contact Michael
Goldberg, Esquire, of Glancy Binkow & Goldberg LLP, 1925 Century
Park East, Suite 2100, Los Angeles, California 90067, Toll-Free at (888)
773-9224, or contact Gregory
Linkh, Esquire, of Glancy Binkow & Goldberg LLP at 122 E. 42nd
Street, Suite 2920, New York, New York 10168, at (212) 682-5340, by
e-mail to email@example.com,
or visit our website at http://www.glancylaw.com.
If you inquire by email, please include your mailing address, telephone
number and number of shares purchased.
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.
[ Back To Technology News's Homepage ]